In this episode of CIO Leadership Live, Lucas Mearian speaks with Yogaraj “Yogs” Jayaprakasam, Chief Technology and Digital Officer at Deluxe, about the company’s transformation from a traditional ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting Drivers of DMD Cardiomyopathy New Data Confirm TN-301’s Differentiated Mechanism and Opportunities to ...
The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results